Does the media prefer GRDN or HNGE?

In the previous week, Hinge Health had 9 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 10 mentions for Hinge Health and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Hinge Health's score of 0.55 indicating that Guardian Pharmacy Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HIMS or GRDN?

In the previous week, Hims & Hers Health had 42 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 43 mentions for Hims & Hers Health and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Hims & Hers Health's score of 0.06 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 5 Very Positive mention(s) 3 Positive mention(s) 32 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Guardian Pharmacy Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CHE or GRDN?

In the previous week, Chemed had 7 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 8 mentions for Chemed and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Chemed's score of 0.13 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Guardian Pharmacy Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer GRDN or BLLN?

In the previous week, Billiontoone had 7 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 8 mentions for Billiontoone and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Billiontoone's score of 0.14 indicating that Guardian Pharmacy Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer GRDN or RDNT?

In the previous week, RadNet had 5 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 6 mentions for RadNet and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat RadNet's score of 0.60 indicating that Guardian Pharmacy Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Guardian Pharmacy Services (GRDN) Competitors

$41.20 -0.90 (-2.13%)

Closing price 10/6/2026 03:59 PM Eastern

Extended Trading

$41.20 0.00 (-0.01%)

As of 04:09 AM Eastern

Compare

GRDN vs. HNGE, HIMS, CHE, BLLN, and RDNT

Should you buy Guardian Pharmacy Services stock or one of its competitors? Guardian Pharmacy Services's main competitors and comparable companies include Hinge Health (HNGE), Hims & Hers Health (HIMS), Chemed (CHE), Billiontoone (BLLN), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Guardian Pharmacy Services compare to Hinge Health?

Guardian Pharmacy Services (NYSE:GRDN) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Guardian Pharmacy Services has higher revenue and earnings than Hinge Health. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.42	$49.22M	$1.03	40.00
Hinge Health	$587.86M	13.49	-$528.26M	$1.28	76.78

Guardian Pharmacy Services has a beta of 0.03, indicating that its share price is 97% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

Guardian Pharmacy Services currently has a consensus price target of $45.57, indicating a potential upside of 10.60%. Hinge Health has a consensus price target of $105.33, indicating a potential upside of 7.19%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, research analysts clearly believe Guardian Pharmacy Services is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89

In the previous week, Hinge Health had 9 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 10 mentions for Hinge Health and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Hinge Health's score of 0.55 indicating that Guardian Pharmacy Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health has a net margin of 15.15% compared to Guardian Pharmacy Services' net margin of 4.50%. Hinge Health's return on equity of 51.60% beat Guardian Pharmacy Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Hinge Health	15.15%	51.60%	14.16%

Summary

Hinge Health beats Guardian Pharmacy Services on 9 of the 15 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Guardian Pharmacy Services (NYSE:GRDN) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

Hims & Hers Health has a beta of 2.44, indicating that its stock price is 144% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.03, indicating that its stock price is 97% less volatile than the broader market.

Guardian Pharmacy Services has a net margin of 4.50% compared to Hims & Hers Health's net margin of -5.51%. Guardian Pharmacy Services' return on equity of 29.97% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

Hims & Hers Health currently has a consensus price target of $32.43, indicating a potential upside of 10.07%. Guardian Pharmacy Services has a consensus price target of $45.57, indicating a potential upside of 10.60%. Given Guardian Pharmacy Services' stronger consensus rating and higher probable upside, analysts clearly believe Guardian Pharmacy Services is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90

Hims & Hers Health has higher revenue and earnings than Guardian Pharmacy Services. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.93	$128.37M	-$0.63	N/A
Guardian Pharmacy Services	$1.45B	1.42	$49.22M	$1.03	40.00

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 42 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 43 mentions for Hims & Hers Health and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Hims & Hers Health's score of 0.06 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	5 Very Positive mention(s)	3 Positive mention(s)	32 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardian Pharmacy Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Guardian Pharmacy Services beats Hims & Hers Health on 10 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Chemed?

Chemed (NYSE:CHE) and Guardian Pharmacy Services (NYSE:GRDN) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

95.9% of Chemed shares are held by institutional investors. 3.3% of Chemed shares are held by insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Chemed has a net margin of 10.60% compared to Guardian Pharmacy Services' net margin of 4.50%. Chemed's return on equity of 31.77% beat Guardian Pharmacy Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

Chemed has higher revenue and earnings than Guardian Pharmacy Services. Chemed is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.64	$265.24M	$19.91	25.63
Guardian Pharmacy Services	$1.45B	1.42	$49.22M	$1.03	40.00

In the previous week, Chemed had 7 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 8 mentions for Chemed and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Chemed's score of 0.13 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardian Pharmacy Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemed presently has a consensus price target of $554.60, indicating a potential upside of 8.67%. Guardian Pharmacy Services has a consensus price target of $45.57, indicating a potential upside of 10.60%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, analysts clearly believe Guardian Pharmacy Services is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90

Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.03, indicating that its stock price is 97% less volatile than the broader market.

Summary

Chemed beats Guardian Pharmacy Services on 10 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Billiontoone?

Guardian Pharmacy Services (NYSE:GRDN) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Guardian Pharmacy Services has higher revenue and earnings than Billiontoone. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.42	$49.22M	$1.03	40.00
Billiontoone	$305.11M	15.46	$7.45M	$0.70	142.77

Guardian Pharmacy Services currently has a consensus target price of $45.57, indicating a potential upside of 10.60%. Billiontoone has a consensus target price of $126.25, indicating a potential upside of 26.33%. Given Billiontoone's higher possible upside, analysts clearly believe Billiontoone is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55

In the previous week, Billiontoone had 7 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 8 mentions for Billiontoone and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat Billiontoone's score of 0.14 indicating that Guardian Pharmacy Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone has a net margin of 8.04% compared to Guardian Pharmacy Services' net margin of 4.50%. Guardian Pharmacy Services' return on equity of 29.97% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Billiontoone	8.04%	9.96%	5.35%

Summary

Guardian Pharmacy Services beats Billiontoone on 8 of the 13 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to RadNet?

Guardian Pharmacy Services (NYSE:GRDN) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Guardian Pharmacy Services has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45B	1.42	$49.22M	$1.03	40.00
RadNet	$2.04B	2.71	-$18.65M	-$0.27	N/A

In the previous week, RadNet had 5 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 6 mentions for RadNet and 1 mentions for Guardian Pharmacy Services. Guardian Pharmacy Services' average media sentiment score of 1.05 beat RadNet's score of 0.60 indicating that Guardian Pharmacy Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardian Pharmacy Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardian Pharmacy Services has a beta of 0.03, meaning that its stock price is 97% less volatile than the broader market. Comparatively, RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

Guardian Pharmacy Services currently has a consensus target price of $45.57, suggesting a potential upside of 10.60%. RadNet has a consensus target price of $90.00, suggesting a potential upside of 28.06%. Given RadNet's higher probable upside, analysts plainly believe RadNet is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

77.9% of RadNet shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by company insiders. Comparatively, 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Guardian Pharmacy Services has a net margin of 4.50% compared to RadNet's net margin of -0.93%. Guardian Pharmacy Services' return on equity of 29.97% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
RadNet	-0.93%	2.61%	0.91%

Summary

Guardian Pharmacy Services beats RadNet on 10 of the 17 factors compared between the two stocks.

Get Guardian Pharmacy Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRDN vs. The Competition

Export

Metric	Guardian Pharmacy Services	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$2.10B	$9.84B	$7.19B	$22.90B
Dividend Yield	N/A	2.60%	2.53%	3.72%
P/E Ratio	40.01	33.82	273.94	28.15
Price / Sales	1.42	4.92	644.57	14.87
Price / Cash	33.42	118.45	79.41	36.95
Price / Book	11.98	5.14	10.89	4.72
Net Income	$49.22M	$315.68M	$3.50B	$1.07B
7 Day Performance	0.60%	-0.77%	-2.04%	1.31%
1 Month Performance	0.75%	-2.90%	-7.03%	-4.97%
1 Year Performance	73.73%	9.94%	5.86%	6.66%

Guardian Pharmacy Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRDN Guardian Pharmacy Services	3.296 of 5 stars	$41.21 -2.1%	$45.57 +10.6%	+73.6%	$2.10B	$1.45B	40.01	3,600	Positive News
HNGE Hinge Health	3.6703 of 5 stars	$97.51 +2.4%	$105.33 +8.0%	+89.3%	$7.68B	$587.86M	76.18	1,437
HIMS Hims & Hers Health	2.2448 of 5 stars	$29.76 +3.7%	$32.43 +9.0%	-46.1%	$6.70B	$2.35B	N/A	2,442	Trending News
CHE Chemed	3.4134 of 5 stars	$505.60 -1.3%	$554.60 +9.7%	+17.3%	$6.69B	$2.53B	25.39	15,811
BLLN Billiontoone	3.9608 of 5 stars	$106.44 -9.9%	$125.88 +18.3%	N/A	$5.58B	$305.11M	152.06	713

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:GRDN) was last updated on 10/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardian Pharmacy Services (GRDN) Competitors

GRDN vs. HNGE, HIMS, CHE, BLLN, and RDNT

How does Guardian Pharmacy Services compare to Hinge Health?

Summary

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Summary

How does Guardian Pharmacy Services compare to Chemed?

Summary

How does Guardian Pharmacy Services compare to Billiontoone?

Summary

How does Guardian Pharmacy Services compare to RadNet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRDN vs. The Competition

Guardian Pharmacy Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardian Pharmacy Services (GRDN) Competitors

GRDN vs. HNGE, HIMS, CHE, BLLN, and RDNT

How does Guardian Pharmacy Services compare to Hinge Health?

Which has better valuation and earnings, GRDN or HNGE?

Which has more volatility and risk, GRDN or HNGE?

Do analysts rate GRDN or HNGE?

Does the media prefer GRDN or HNGE?

Is GRDN or HNGE more profitable?

Summary

How does Guardian Pharmacy Services compare to Hims & Hers Health?

Which has more risk and volatility, HIMS or GRDN?

Is HIMS or GRDN more profitable?

Do analysts prefer HIMS or GRDN?

Which has higher valuation & earnings, HIMS or GRDN?

Do institutionals & insiders hold more shares of HIMS or GRDN?

Does the media prefer HIMS or GRDN?

Summary

How does Guardian Pharmacy Services compare to Chemed?

Do institutionals and insiders believe in CHE or GRDN?

Is CHE or GRDN more profitable?

Which has preferable earnings & valuation, CHE or GRDN?

Does the media refer more to CHE or GRDN?

Do analysts recommend CHE or GRDN?

Which has more volatility & risk, CHE or GRDN?

Summary

How does Guardian Pharmacy Services compare to Billiontoone?

Which has better valuation & earnings, GRDN or BLLN?

Do analysts prefer GRDN or BLLN?

Does the media prefer GRDN or BLLN?

Is GRDN or BLLN more profitable?

Summary

How does Guardian Pharmacy Services compare to RadNet?

Which has stronger earnings & valuation, GRDN or RDNT?

Does the media prefer GRDN or RDNT?

Which has more volatility & risk, GRDN or RDNT?

Do analysts recommend GRDN or RDNT?

Do insiders & institutionals hold more shares of GRDN or RDNT?

Is GRDN or RDNT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRDN vs. The Competition

Guardian Pharmacy Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools